An abnormality in basement membrane metabolism has been postulated to play an important role in the pathogenesis of experimental murine AA amyloidosis. The potential contribution of the structural basement membrane proteins laminin, type IV collagen and entactin to amyloidogenesis in this model was investigated with a kinetic analysis of the expression of the corresponding genes during amyloid formation. Splenic AA amyloid deposition was stimulated by the concomitant administration of subcutaneous silver nitrate, as art inflammatory stimulus and intravenous amyloid enhancing factor. Using a reverse transcription-polymerase chain reaction assay; a differential pattern of expression of these genes seas observed at the mRNA level. Whereas laminin BI mRNA levels did not change at any time during amyloidogenesis, a 2.2 to 3 fold induction of laminin B2, entactin and alpha 1-type IV collagen mRNAs coincided with the initial detection of splenic amyloid deposits at 48 hours post-stimulation as detected by immunohistochemistry. Temporal and spatial code position of laminin and type IV collagen with amyloid was demonstrated by immunohistochemistry. A 1.4 2.3 and 2.2-fold increase in laminin BZ, entactin and alpha 1-type IV collagen mRNA levels, respectively, was detected at 24 hours post-stimulation, a paint at which amyloid deposits could not be detected Neither inflammation nor amyloid enhancing factor alone influenced laminin, entactin or typo IV collagen expression at the protein or mRNA level. These observations suggest that the laminin B2 chain and al-type IV collagen chain account, at least in part, for the observed laminin and collagen TY immunoreactivity in AA amyloid deposits and that entactin may also be a component of the amyloid deposit. The onset of the induction of laminin B2, entactin and alpha 1-type IV collagen gene expression prior to the appearance of amyloid deposits, and our previous data with the heparan sulfate proteoglycan, perlecan, suggests these basement membrane proteins may play a role in the initial stages of AA fibrillogenesis.